Post-herpetic neuralgia and shingles pain management face new hurdles as recent research links circulating blood microparticles to persistent nerve damage, according to a study published in the journal Annals of Neurology. Over 90% of the world’s population contracts the varicella zoster virus that causes chickenpox, typically during early childhood in temperate regions or adolescence and early adulthood in tropical regions, according to researchers. After the initial infection, the virus remains dormant within pain-sensing neurons, even in individuals who received the live weakened strain of the varicella vaccine used in the United States since 1995. The virus reactivates decades later as a painful shingles rash in roughly a third of the world’s population, with global rates currently increasing for reasons researchers do not yet fully understand.
Exosomes Drive Persistent Neuropathic Pain
While most shingles patients recover within a couple of weeks, about 10% to 18% develop post-herpetic neuralgia months after the rash clears, leaving them with pain that can last for years or a lifetime, according to study findings. Skin biopsies of post-herpetic neuralgia patients reveal a puzzling reduction in sensory nerve fibers in painful areas despite normal-looking skin, and what prevents these fibers from repairing remains unknown. To investigate noninfectious contributors, researchers isolated microparticles called exosomes from the blood of seven patients with post-herpetic neuralgia and seven patients without the condition. According to the study, exosomes carry bioactive cargo like proteins and nucleic acids that alter recipient cell behavior. The team found that exosomes from post-herpetic neuralgia patients contained significantly higher concentrations of proteins that suppress neuron growth. When human sensory neurons in a petri dish were exposed to these exosomes, live-cell imaging showed the neurons were significantly stunted, unable to form strong networks, and driven into an overactive, hypersensitive state that prevents growth cone formation.
Antiviral Limitations and Current Treatment Options
Antiviral treatments that shut down viral replication do not reliably prevent or reduce post-herpetic neuralgia, pushing neurovirologists to explore noninfectious mechanisms. Prescription antiviral medications such as acyclovir (Zovirax), valacyclovir (Valtrex), and famciclovir (Famvir) can reduce the length and severity of a shingles outbreak and help prevent post-herpetic neuralgia if administered early enough. Additional management strategies for shingles and post-herpetic neuralgia include over-the-counter or prescription pain relievers, nonsteroidal anti-inflammatory drugs, and narcotic medications depending on severity. Nonmedical home remedies include cool compresses, anti-itching lotions like calamine lotion, and aluminum acetate solutions to dry up blisters. Furthermore, tricyclic antidepressants, antiseizure medications, topical capsaicin cream, and lidocaine patches are frequently utilized to control post-herpetic neuralgia pain.
Future Implications for Chronic Neuropathy Treatments
Targeting the underlying cause behind nerve irritation and failed regeneration could lead to more effective treatments for post-herpetic neuralgia by addressing the source of the pain, according to the research team. Investigators believe this exosome-driven phenomenon likely extends to other painful neuropathies associated with failed nerve regeneration, such as diabetic neuropathy. Current laboratory efforts involve collecting sequential blood samples for up to a year from shingles patients who develop post-herpetic neuralgia and comparing them with patients whose shingles resolves without lingering pain. This comparison aims to determine the specific cargo exosomes carry that contributes to this debilitating chronic pain condition, which can cause severe emotional distress and suicidal thoughts alongside a significant decline in quality of life.
Did You Know?
Less than 50% of patients with post-herpetic neuralgia achieve meaningful pain relief because underlying mechanisms driving persistent pain remain largely unknown and current treatments only focus on relieving symptoms.
Frequently Asked Questions
What is post-herpetic neuralgia?
Post-herpetic neuralgia is a complication of shingles characterized by nerve pain that lasts longer than three months after the shingles rash has disappeared, according to medical researchers.
What are exosomes?
Exosomes are noninfectious microscopic particles released from every cell type in the body that carry bioactive cargo like proteins and nucleic acids to shuttle signals between cells, according to the Annals of Neurology study.
Can antiviral drugs prevent post-herpetic neuralgia?
Prescription antiviral medications like acyclovir, valacyclovir, and famciclovir can help prevent the development of post-herpetic neuralgia and reduce its duration if given early enough during an outbreak.
Who is at risk for developing post-herpetic neuralgia?
Anyone who contracts shingles is at risk of developing post-herpetic neuralgia, though the risk rises significantly with age, according to researchers.
Stay Informed on Health Research
Keep reading